Turkish Adaptation of the CSQ-VR
Turkish Validity and Reliability of CyberSickness in Virtual Reality Questionnaire
1 other identifier
observational
42
1 country
1
Brief Summary
The Cybersickness in Virtual Reality Questionnaire (CSQ-VR) is a tool designed to measure the presence and intensity of cybersickness symptoms experienced in VR. The CSQ-VR is an adapted and improved version of the Cybersickness section of the Virtual Reality Neuroscience Questionnaire (VRNQ). The aim of this study is to examine the validity and reliability of the Turkish version of the CSQ-VR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2025
CompletedFirst Posted
Study publicly available on registry
November 25, 2025
CompletedStudy Start
First participant enrolled
December 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 15, 2028
November 25, 2025
October 1, 2025
2 years
November 18, 2025
November 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cybersickness in Virtual Reality Questionnaire
It is a tool designed to measure the presence and severity of cybersickness symptoms experienced in VR
Immediately after a single VR session (~1 hour)
Secondary Outcomes (1)
Simulator Sickness Questionnaire
Immediately after a single VR session (~1 hour)
Study Arms (1)
Healthy volunteer
A group of healthy participants will rate the symptoms induced in virtual reality using questionnaire items.
Eligibility Criteria
Healthy volunteers aged 18-30 years with independent standing and walking ability will be recruited.
You may qualify if:
- Voluntary agreement to participate in the study
- Ability to stand and walk independently
You may not qualify if:
- Presence of amblyopia, strabismus, or pathologies impairing focus, depth perception, or normal 3D vision
- Failure on the butterfly test of the Titmus stereotest
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Abant Izzet Baysal University Faculty of Health Science
Bolu, Bolu, 14100, Turkey (Türkiye)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 18, 2025
First Posted
November 25, 2025
Study Start
December 15, 2025
Primary Completion (Estimated)
December 15, 2027
Study Completion (Estimated)
January 15, 2028
Last Updated
November 25, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
No, individual participant data (IPD) will not be made available to other researchers.